Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study

[1]  M. Aseeri,et al.  Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia. , 2017, Journal of infection and public health.

[2]  A. Karban,et al.  [REDUCTION OF ANTIBIOTIC CONSUMPTION IN RAMBAM HEALTH CARE CAMPUS - THE ROLE OF AN ANTIBIOTIC STEWARDSHIP PROGRAM]. , 2017, Harefuah.

[3]  J. Al-Tawfiq,et al.  Benchmarking of antibiotic usage: An adjustment to reflect antibiotic stewardship program outcome in a hospital in Saudi Arabia , 2017, Journal of Infection and Public Health.

[4]  Fawzia E. Alotaibi,et al.  Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes , 2017, Journal of Infection and Public Health.

[5]  R. Guy,et al.  Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips. , 2016, The Journal of antimicrobial chemotherapy.

[6]  E. Vallières,et al.  [Antibiotic consumption and bacterial sensitivity in a teaching hospital: A 5-year study]. , 2016, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[7]  D. Pittet,et al.  The strategic plan for combating antimicrobial resistance in Gulf Cooperation Council States. , 2016, Journal of infection and public health.

[8]  M. Garbati,et al.  Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study , 2016, BioMed research international.

[9]  D. Buckeridge,et al.  A Simulation Study to Assess Indicators of Antimicrobial Use as Predictors of Resistance: Does It Matter Which Indicator Is Used? , 2015, PloS one.

[10]  J. Losa,et al.  [Measurement of antimicrobial consumption using DDD per 100 bed-days versus DDD per 100 discharges after the implementation of an antimicrobial stewardship program]. , 2015, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[11]  O. Vanderkooi,et al.  Antimicrobial use over a four-year period using days of therapy measurement at a Canadian pediatric acute care hospital , 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[12]  Marc Mendelson,et al.  The World Health Organization Global Action Plan for antimicrobial resistance. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[13]  C. L. Ventola.  The antibiotic resistance crisis: part 1: causes and threats. , 2015, P & T : a peer-reviewed journal for formulary management.

[14]  P. Sánchez,et al.  Prospective Surveillance of Antibiotic Use in the Neonatal Intensive Care Unit: Results From the SCOUT Study , 2015, The Pediatric infectious disease journal.

[15]  J. Bergs,et al.  Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis , 2015, Critical Care.

[16]  Y. Arabi,et al.  Drug-resistant ventilator associated pneumonia in a tertiary care hospital in Saudi Arabia , 2014, Annals of thoracic medicine.

[17]  A. Dashti,et al.  Molecular Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: Dominance of OXA-48 and NDM Producers , 2014, Antimicrobial Agents and Chemotherapy.

[18]  Y. Carmeli,et al.  Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance , 2013, Clinical Microbiology Reviews.

[19]  J. Al-Tawfiq.  Changes in the pattern of hospital intravenous antimicrobial use in Saudi Arabia, 2006–2008 , 2012, Annals of Saudi medicine.

[20]  A. Bombassaro,et al.  Antimicrobial use in a critical care unit: a prospective observational study , 2012, The International journal of pharmacy practice.

[21]  M. Al-Ahdal,et al.  The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go? , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[22]  S. Hohmann,et al.  Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Clarke,et al.  What is a systematic review? , 2011, Evidence Based Nursing.

[24]  N. Daneman,et al.  Impact of antimicrobial stewardship in critical care: a systematic review. , 2011, The Journal of antimicrobial chemotherapy.

[25]  D. Paterson,et al.  Antimicrobial Utilisation in 37 Australian and New Zealand Intensive Care Units , 2011, Anaesthesia and intensive care.

[26]  Surbhi Leekha,et al.  General Principles of Antimicrobial Therapy , 2011, Mayo Clinic proceedings.

[27]  S. Boussat,et al.  Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. , 2010, The Journal of antimicrobial chemotherapy.

[28]  H. Lode.  Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. , 2010, The American journal of medicine.

[29]  D. Maki,et al.  International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. , 2008, American journal of infection control.

[30]  E. Poluzzi,et al.  A 3 year survey on the use of antibacterial agents in five Italian hospitals. , 2008, The Journal of antimicrobial chemotherapy.

[31]  T. Schiano,et al.  Review article: drug hepatotoxicity , 2007, Alimentary pharmacology & therapeutics.

[32]  R. Polk,et al.  Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  P. Gastmeier,et al.  Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units (SARI): A Summary of the Data from 2001 through 2004 , 2006, Infection.

[34]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[35]  Nnis System.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[36]  O. Cars,et al.  Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units , 2002, Acta anaesthesiologica Scandinavica.

[37]  D. Monnet,et al.  Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. , 2000, International journal of antimicrobial agents.

[38]  J. E. Losa,et al.  Evaluación del consumo de antimicrobianos mediante DDD/100 estancias versus DDD/100 altas en la implantación de un Programa de Optimización del Uso de Antimicrobianos , 2015 .

[39]  H. Goossens,et al.  Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. , 2010, The Lancet. Infectious diseases.

[40]  A. Berrington.  Antimicrobial prescribing in hospitals: be careful what you measure. , 2010, The Journal of antimicrobial chemotherapy.

[41]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[42]  Organización Mundial de la Salud.  Guidelines for ATC classification and DDD assignment , 1996 .